UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The epidemiology of non-Hodgkin's lymphoma

Oncogene, 2004-08, Vol.23 (38), p.6524-6534

2004

Volltextzugriff (PDF)

New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

Journal of clinical oncology, 2005-11, Vol.23 (33), p.8447-8452

2005

Volltextzugriff (PDF)

Thromboembolism in Hospitalized Neutropenic Cancer Patients

Journal of clinical oncology, 2006-01, Vol.24 (3), p.484-490

2006

Volltextzugriff (PDF)

Incidence and Predictors of Low Chemotherapy Dose-Intensity in Aggressive Non-Hodgkin's Lymphoma: A Nationwide Study

Journal of clinical oncology, 2004-11, Vol.22 (21), p.4302-4311

2004

Volltextzugriff (PDF)

Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup Trial

Journal of clinical oncology, 2003-02, Vol.21 (4), p.607-614

2003

Volltextzugriff (PDF)

A Clinical Analysis of Two Indolent Lymphoma Entities: Mantle Cell Lymphoma and Marginal Zone Lymphoma (Including the Mucosa-Associated Lymphoid Tissue and Monocytoid B-Cell Subcategories): A Southwest Oncology Group Study

Blood, 1995-02, Vol.85 (4), p.1075-1082

1995

Volltextzugriff (PDF)

Tositumomab and Iodine-131 Tositumomab Produces Durable Complete Remissions in a Subset of Heavily Pretreated Patients With Low-Grade and Transformed Non-Hodgkin’s Lymphomas

Journal of clinical oncology, 2005-10, Vol.23 (30), p.7565-7573

2005

Volltextzugriff (PDF)

High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993

Journal of clinical oncology, 1999-07, Vol.17 (7), p.2105-2116

1999

Volltextzugriff (PDF)

Meta-Analysis to Evaluate the Role of Interferon in Follicular Lymphoma

Journal of clinical oncology, 2005-04, Vol.23 (10), p.2215-2223

2005

Volltextzugriff (PDF)

Aggressive Treatment for Postcardiac Transplant Lymphoproliferation

Blood, 1995-11, Vol.86 (9), p.3333-3340

1995

Volltextzugriff (PDF)

Phase II Study of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated, Aggressive Non-Hodgkin’s Lymphoma

Journal of clinical oncology, 2001-01, Vol.19 (2), p.389-397

2001

Volltextzugriff (PDF)

Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

Journal of clinical oncology, 1999-04, Vol.17 (4), p.1244-1253

1999

Volltextzugriff (PDF)

Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma

The New England journal of medicine, 1998-07, Vol.339 (1), p.21-26

1998

Volltextzugriff (PDF)

Lymphoma classification--the gap between biology and clinical management is closing

Blood, 1996-12, Vol.88 (11), p.4085-4089

1996

Volltextzugriff (PDF)

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911

Blood, 2003-09, Vol.102 (5), p.1606-1612

2003

Volltextzugriff (PDF)

Lymphoma classification : The gap between biology and clinical management is closing

Blood, 1996-12, Vol.88 (11), p.4085-4089

1996

Volltextzugriff (PDF)

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy

Journal of clinical oncology, 1995-03, Vol.13 (3), p.688-696

1995

Volltextzugriff (PDF)

Current trends in large cell lymphoma

Leukemia, 2003-10, Vol.17 (10), p.1948-1960

2003

Volltextzugriff (PDF)

Phase III Randomized Intergroup Trial of Subtotal Lymphoid Irradiation Versus Doxorubicin, Vinblastine, and Subtotal Lymphoid Irradiation for Stage IA to IIA Hodgkin’s Disease

Journal of clinical oncology, 2001-11, Vol.19 (22), p.4238-4244

2001

Volltextzugriff (PDF)

Health Status and Quality of Life in Patients With Early-Stage Hodgkin’s Disease Treated on Southwest Oncology Group Study 9133

Journal of clinical oncology, 2003-09, Vol.21 (18), p.3512-3519

2003

Volltextzugriff (PDF)

A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

The New England journal of medicine, 1993-09, Vol.329 (14), p.987-994

1993

Volltextzugriff (PDF)

The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features

Blood, 2001-06, Vol.97 (12), p.3713-3720

2001

Volltextzugriff (PDF)

1 – 25 von 253

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(180)

Publikationsform

Artikel
(252)
Berichte
(1)

Sprache

Englisch
(252)
Japanisch
(34)

Erscheinungsjahr

n.n

Thema

Science & Technology
(232)
Life Sciences & Biomedicine
(215)
Humans
(198)
Female
(119)
Oncology
(118)
Male
(112)
Middle Aged
(112)
Adult
(100)
Biological And Medical Sciences
(96)
Medical Sciences
(89)
Aged
(84)
Pharmacology. Drug Treatments
(47)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(44)
Antineoplastic Agents
(41)
Lymphoma, Non-Hodgkin - Drug Therapy
(34)
Hematologic And Hematopoietic Diseases
(28)
Immunology
(28)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(28)
Doxorubicin - Administration & Dosage
(27)
Hematology
(27)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The epidemiology of non-Hodgkin's lymphoma

New Treatment Options Have Changed the Survival of Patients With Follicular Lymphoma

Thromboembolism in Hospitalized Neutropenic Cancer Patients

Incidence and Predictors of Low Chemotherapy Dose-Intensity in Aggressive Non-Hodgkin's Lymphoma: A Nationwide Study

Randomized Comparison of ABVD and MOPP/ABV Hybrid for the Treatment of Advanced Hodgkin’s Disease: Report of an Intergroup Trial

A Clinical Analysis of Two Indolent Lymphoma Entities: Mantle Cell Lymphoma and Marginal Zone Lymphoma (Including the Mucosa-Associated Lymphoid Tissue and Monocytoid B-Cell Subcategories): A Southwest Oncology Group Study

Tositumomab and Iodine-131 Tositumomab Produces Durable Complete Remissions in a Subset of Heavily Pretreated Patients With Low-Grade and Transformed Non-Hodgkin’s Lymphomas

Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction

High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993

Meta-Analysis to Evaluate the Role of Interferon in Follicular Lymphoma

Aggressive Treatment for Postcardiac Transplant Lymphoproliferation

Phase II Study of Rituximab in Combination With CHOP Chemotherapy in Patients With Previously Untreated, Aggressive Non-Hodgkin’s Lymphoma

Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

Chemotherapy Alone Compared with Chemotherapy plus Radiotherapy for Localized Intermediate- and High-Grade Non-Hodgkin's Lymphoma

Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project

Lymphoma classification--the gap between biology and clinical management is closing

A phase 2 trial of CHOP chemotherapy followed by tositumomab/iodine I 131 tositumomab for previously untreated follicular non-Hodgkin lymphoma: Southwest Oncology Group Protocol S9911

Lymphoma classification : The gap between biology and clinical management is closing

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy

Current trends in large cell lymphoma

Phase III Randomized Intergroup Trial of Subtotal Lymphoid Irradiation Versus Doxorubicin, Vinblastine, and Subtotal Lymphoid Irradiation for Stage IA to IIA Hodgkin’s Disease

Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions

Health Status and Quality of Life in Patients With Early-Stage Hodgkin’s Disease Treated on Southwest Oncology Group Study 9133

A Predictive Model for Aggressive Non-Hodgkin's Lymphoma

The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features

Suchergebnisse filtern